Consolidated Balance Sheets - USD ($)
$ in Millions |
Nov. 30, 2020 |
Feb. 29, 2020 |
| Current |
|
|
| Cash and cash equivalents (note 3) |
$ 223
|
$ 377
|
| Short-term investments (note 3) |
451
|
532
|
| Accounts receivable, net of allowance of $13 and $9, respectively (note 1 and note 4) |
212
|
215
|
| Other receivables |
21
|
14
|
| Income taxes receivable |
10
|
6
|
| Other current assets (note 4) |
54
|
52
|
| Assets, Current, Total |
971
|
1,196
|
| Restricted cash and cash equivalents (note 3) |
50
|
49
|
| Long-term investments (note 3) |
33
|
32
|
| Other long-term assets (note 4) |
19
|
65
|
| Operating lease right-of-use assets, net |
91
|
124
|
| Property, plant and equipment, net (note 4) |
54
|
70
|
| Goodwill (note 4) |
849
|
1,437
|
| Intangible assets, net (note 4) |
803
|
915
|
| Total assets |
2,870
|
3,888
|
| Current |
|
|
| Accounts payable |
29
|
31
|
| Accrued liabilities (note 4) |
173
|
202
|
| Income taxes payable (note 5) |
8
|
18
|
| Debentures (note 6) |
0
|
606
|
| Deferred revenue, current (note 11) |
217
|
264
|
| Total current liabilities |
427
|
1,121
|
| Deferred revenue, non-current (note 11) |
75
|
109
|
| Operating lease liabilities |
99
|
120
|
| Other long-term liabilities (note 4) |
7
|
9
|
| Long-term debentures (note 6) |
459
|
0
|
| Total liabilities |
1,067
|
1,359
|
| Capital stock and additional paid-in capital |
|
|
| Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable |
0
|
0
|
| Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 562,015,875 voting common shares (February 29, 2020 - 554,199,016) |
2,803
|
2,760
|
| Deficit |
(991)
|
(198)
|
| Accumulated other comprehensive loss (note 9) |
(9)
|
(33)
|
| Total shareholders' equity |
1,803
|
2,529
|
| Total liabilities and shareholders' equity |
$ 2,870
|
$ 3,888
|